Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2531730010 | Erlotinib (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 2535285016 | Erlotinib | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Erlotinib (substance) | Is a | Substance with ether structure | true | Inferred relationship | Some | ||
| Erlotinib (substance) | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Erlotinib (substance) | Is a | Substance categorized by disposition | true | Inferred relationship | Some | ||
| Erlotinib (substance) | Has disposition (attribute) | Disposition | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Erlotinib only product | Has active ingredient | True | Erlotinib (substance) | Inferred relationship | Some | 1 |
| Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Erlotinib (substance) | Inferred relationship | Some | 1 |
| Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Erlotinib (substance) | Inferred relationship | Some | 1 |
Reference Sets
FHIR